Katy Moore, Pharm. D., R.Ph.
President, Clinical Pharmacology Modeling and Simulation
Katy Moore has more than 29 years in Pharmaceutical Industry. Prior to joining Allucent, Moore served as the Global Head of Clinical Pharmacology for ViiV Healthcare, where she created business solutions with diverse partners by providing strategy, oversight, and application of Clinical Pharmacology and Model Informed Drug Development. She founded and was co-chair of the ViiV Healthcare Protocol Review Forum for Ph1-2a studies and was a valued member of various governance and review committees. Moore started the ViiV Healthcare internship, which accompanies a career-long commitment to mentoring and education.
Prior to ViiV Healthcare, Moore held several positions in GlaxoWellcome and GSK Clinical Pharmacology Modeling and Simulation of increasing breadth and responsibility. Moore led Viral Diseases and Oncology Clinical Pharmacology Modeling and Simulation teams, was on the Clinical Pharmacology Modeling and Simulation Leadership Team, Oncology Early Development Unit Leadership Team, a member of the Clinical Pharmacology Protocol Review Forum and Steering Committee. Throughout her career, Moore has made significant contributions to the development of numerous medicines for the treatment and prevention of disease for HIV, other viral diseases and cancer including worldwide regulatory submission and commercialization.
In addition to her leadership in GSK CPMS, in 2011 she joined GSK Worldwide Business Development in Scientific Licensing, where she led multidisciplinary teams on the search, evaluation and review of preclinical, clinical, platform and divestment opportunities for cell therapies, biopharmaceuticals, and NCEs. Deals included R&D and strategic collaboration and licensing agreements, co-development and marketing agreement, non-profit collaboration and funding agreement, Newco creation and others.
Moore’s undergraduate training was in Biological Sciences, Zoology and Pharmacy at the Colorado State University and University of Colorado, respectively. She earned a PharmD from UNC School of Pharmacy and was a Glaxo post-doctoral fellow in clinical pharmacology/modeling and simulation. Moore joined the Pharmaceutical Industry in Clinical Pharmacology from the UNC, School of Pharmacy, Department of Pharmaceutics. Moore is a registered pharmacist, has over 94 publications and has been a frequent invited speaker on Clinical Pharmacology and business development topics.